Brokers Issue Forecasts for TSE:CPH FY2027 Earnings

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) – Analysts at Leede Financial issued their FY2027 earnings estimates for shares of Cipher Pharmaceuticals in a research note issued to investors on Wednesday, March 19th. Leede Financial analyst D. Loe forecasts that the company will earn $1.10 per share for the year. The consensus estimate for Cipher Pharmaceuticals’ current full-year earnings is $1.29 per share.

Cipher Pharmaceuticals Stock Performance

CPH opened at C$12.32 on Monday. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. The company has a market capitalization of C$221.18 million, a price-to-earnings ratio of 13.61 and a beta of 1.20. Cipher Pharmaceuticals has a 1 year low of C$7.90 and a 1 year high of C$19.69. The business’s 50-day moving average price is C$12.85 and its two-hundred day moving average price is C$14.38.

Insider Buying and Selling at Cipher Pharmaceuticals

In other Cipher Pharmaceuticals news, Director Harold Morton Wolkin sold 3,500 shares of Cipher Pharmaceuticals stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total value of C$47,215.00. Company insiders own 42.00% of the company’s stock.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.